International Monetary Fund boss Christine Lagarde is being investigated by French prosecutors regarding a rare and minor charge of negligence in the use of public funds
The bidder's chief executive said he won't take no for an answer, and Dollar General's quarterly results show why
The law says campaigns and interest groups can’t coordinate, but that doesn’t stop them
A few years ago, big media companies were filing copyright lawsuits against YouTube. Now they’re buying in
There is increasing government and market scrutiny on for-profit schools, whose business model depends on enrollment
Chermayeff & Geismar has designed some of the most memorable corporate identities. But you may not have heard of them
At 56, the Purple One is fantastic in concert, but he hasn't made a really good album in years
Expenses surrounding cover-ups, legal counsel and support services can reach into the millions when sexual abuse scandals roil campuses, and insurance companies are obliging with new policies.
The St. Louis suburb's businesses face enormous challenges
Kathy Callender, 67
After 12 years in business, PharmaJet may finally be able to sell its first product: a simple, needle-free injection device with a disposable syringe designed for use in third-world countries that can help prevent injury and the spread of disease. The company just received clearance from the Food & Drug Administration to use the tool for vaccines and injectable medicines. The 25-person company has not recorded any revenues to date, but plans to start selling its devices this year. So far, it has been developing the product with help from angel investors. "I want to make a difference in global world health," says Callender, a 35-year veteran of the health-care industry. "Before starting the firm, my husband and I would do medical mission work in the developing world, and it really just showed us how much need there is out there. I want to get needles out of the garbage and prevent injury to workers and patients."